Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.
Li Y, Zheng X, Yi X, Liu C, Kong D, Zhang J, Gong M.
Li Y, et al. Among authors: zhang j.
FASEB J. 2017 Jun;31(6):2603-2611. doi: 10.1096/fj.201601339R. Epub 2017 Mar 7.
FASEB J. 2017.
PMID: 28270518
Free PMC article.
Further structural modifications on myricetin might improve its pharmacology and pharmacokinetics.-Li, Y., Zheng, X., Yi, X., Liu, C., Kong, D., Zhang, J., Gong, M. Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.. …
Further structural modifications on myricetin might improve its pharmacology and pharmacokinetics.-Li, Y., Zheng, X., Yi, X., Liu, C., Kong, …